AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
82.44%
Total 13F principal
$305,304,940
Principal change
-$258,000
Total reported market value
$254,761,000
Number of holders
23
Value change
-$162,879
Number of buys
6
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q3 2019

As of 30 Sep 2019, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 23 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $305,304,940 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Whitebox Advisors LLC, CNH PARTNERS LLC, UBS OCONNOR LLC, WOLVERINE ASSET MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Allianz Asset Management GmbH, Birch Grove Capital LP, DEUTSCHE BANK AG\, and Context Capital Management, LLC. This page lists 23 institutional bondholders reporting positions for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.